Winston Pharmaceuticals (Winston Pharmaceuticals) FCF Margin % : -279.18% (As of Mar. 2010)

View and export this data going back to 2006. Start your Free Trial

What is Winston Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Winston Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2010 was $-0.89 Mil. Winston Pharmaceuticals's Revenue for the three months ended in Mar. 2010 was $0.32 Mil. Therefore, Winston Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2010 was -279.18%.

As of today, Winston Pharmaceuticals's current FCF Yield % is 0.00%.

The historical rank and industry rank for Winston Pharmaceuticals's FCF Margin % or its related term are showing as below:

WPHM' s FCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0
Current: -258.31

WPHM's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.06 vs WPHM: -258.31

Winston Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Winston Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winston Pharmaceuticals FCF Margin % Chart

Winston Pharmaceuticals Annual Data

Trend

Sep05

Sep06

Sep07

Dec08

Dec09

FCF Margin %

-679.47

-301.08

Winston Pharmaceuticals Quarterly Data
	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10
FCF Margin %	Get a 7-Day Free Trial														-452.94	-292.88	-235.33	-225.37	-279.18

Competitive Comparison of Winston Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Winston Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Winston Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Winston Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Winston Pharmaceuticals's FCF Margin % falls into.

Winston Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Winston Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2009 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2009 )	/	Revenue (A: Dec. 2009 )
	=	-4.2	/	1.395
	=	-301.08 %

Winston Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2010 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2010 )	/	Revenue (Q: Mar. 2010 )
	=	-0.885	/	0.317
	=	-279.18 %

Winston Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Winston Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Winston Pharmaceuticals (Winston Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Winston Pharmaceuticals Inc (GREY:WPHM) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 North Fairway Drive, Suite 134, Vernon Hills, IL, USA, 60061

Website

http://www.winstonlabs.com

Winston Pharmaceuticals Inc is a pharmaceutical company, which is engaged in the discovery and development of products for pain management. The company focuses on major pain indications such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo- and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease.

Executives

Frost Phillip Md Et Al	10 percent owner	4400 BISCAYNE BLVD, MIAMI FL 33137-3227
Frost Gamma Investments Trust	10 percent owner	4400 BISCAYNE BLVD, MIAMI FL 33137
Subbarao V Uppaluri	director	4400 BISCAYNE BOULEVARD, SUITE 1500, MIAMI FL 33137
Curtis Lockshin	director	4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Glenn L Halpryn	director	4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Steven Jerry Glauser	10 percent owner	1428 BRICKELL AVENUE, SUITE 105, MIAMI FL 33131
Noah M Silver	director, officer: Vice President	4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Alan Jay Weisberg	director, officer: Chief Financial Officer	2500 NORTH MILITARY TRAIL, SUITE 206, BOCA RATON FL 33431
Stephen Bittel	10 percent owner	4400 BISCAYNE BOULEVARD SUITE 950 MIAMI FL 33137

Winston Pharmaceuticals (Winston Pharmaceuticals) Headlines

No Headlines